|
1
|
Sun D and Gündisch D: Editorial:
Privileged Scaffolds in Natural Products and Drug Discovery. Curr
Top Med Chem. 16:11992016. View Article : Google Scholar
|
|
2
|
Keri RS, Patil MR, Patil SA and Budagumpi
S: A comprehensive review in current developments of
benzothiazole-based molecules in medicinal chemistry. Eur J Med
Chem. 89:207–251. 2015. View Article : Google Scholar
|
|
3
|
Sharma PC, Sinhmar A, Sharma A, Rajak H
and Pathak DP: Medicinal significance of benzothiazole scaffold: An
insight view. J Enzyme Inhib Med Chem. 28:240–266. 2013. View Article : Google Scholar
|
|
4
|
Gill RK, Rawal RK and Bariwal J: Recent
advances in the chemistry and biology of benzothiazoles. Arch Pharm
(Weinheim). 348:155–178. 2015. View Article : Google Scholar
|
|
5
|
Singh M and Singh SK: Benzothiazoles: How
relevant in cancer drug design strategy? Anticancer Agents Med
Chem. 14:127–146. 2014. View Article : Google Scholar
|
|
6
|
Noolvi MN, Patel HM and Kaur M:
Benzothiazoles: Search for anticancer agents. Eur J Med Chem.
54:447–462. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sharma PC, Bansal KK, Deep A and Pathak M:
Benzothiazole derivatives as potential anti-infective agents. Curr
Top Med Chem. 16:12016.
|
|
8
|
Liu Y, Yang T, Li H, Li MH, Liu J, Wang
YT, Yang SX, Zheng J, Luo XY, Lai Y, et al: BD750, a benzothiazole
derivative, inhibits T cell proliferation by affecting the
JAK3/STAT5 signalling pathway. Br J Pharmacol. 168:632–643. 2013.
View Article : Google Scholar :
|
|
9
|
Hroch L, Aitken L, Benek O, Dolezal M,
Kuca K, Gunn-Moore F and Musilek K: Benzothiazoles - scaffold of
interest for CNS targeted drugs. Curr Med Chem. 22:730–747. 2015.
View Article : Google Scholar
|
|
10
|
Kamal A, Syed MA and Mohammed SM:
Therapeutic potential of benzothiazoles: A patent review
(2010–2014). Expert Opin Ther Pat. 25:335–349. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Seth S: A comprehensive review on recent
advances in synthesis & pharmacotherapeutic potential of
benzothiazoles. Antiinflamm Antiallergy Agents Med Chem. 14:98–112.
2015. View Article : Google Scholar
|
|
12
|
Liu Y, Lai Y, Li H, Liu J, Luo XY, Li MH,
Yang T, Wang YT, Yang SX, Li LM, et al: A novel water-soluble
benzothiazole derivative BD926 inhibits human activated T cell
proliferation by down-regulating the STAT5 activation. Eur J
Pharmacol. 761:36–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bhola PD and Letai A: Mitochondria-judges
and executioners of cell death sentences. Mol Cell. 61:695–704.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Farooqi AA, Li KT, Fayyaz S, Chang YT,
Ismail M, Liaw CC, Yuan SS, Tang JY and Chang HW: Anticancer drugs
for the modulation of endoplasmic reticulum stress and oxidative
stress. Tumour Biol. 36:5743–5752. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chaudhari N, Talwar P, Parimisetty A,
Lefebvre d'Hellencourt C and Ravanan P: A molecular web:
Endoplasmic reticulum stress, inflammation, and oxidative stress.
Front Cell Neurosci. 8:2132014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu D, Zhang M and Yin H: Signaling
pathways involved in endoplasmic reticulum stress-induced neuronal
apoptosis. Int J Neurosci. 123:155–162. 2013. View Article : Google Scholar
|
|
17
|
Szegezdi E, Fitzgerald U and Samali A:
Caspase-12 and ER-stress-mediated apoptosis: The story so far. Ann
NY Acad Sci. 1010:186–194. 2003. View Article : Google Scholar
|
|
18
|
Yang Y, Karakhanova S, Hartwig W, D'Haese
JG, Philippov PP, Werner J and Bazhin AV: Mitochondria and
mitochondrial ROS in cancer: Novel targets for anticancer therapy.
J Cell Physiol. Feb 19–2016.(Epub ahead of print). View Article : Google Scholar
|
